Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Richard Pazdur
Biotech
FDA's Richard Pazdur explains confirmatory trial rejection, more
The FDA's oncology chief also challenged biopharma companies to discuss more simplified trial designs with the agency under Project Pragmatica.
Angus Liu
Apr 8, 2024 6:00am
FDA looks to bypass cancer drugs' companion diagnostics: Pazdur
Nov 18, 2022 9:17am
Follow-up trials should be underway for accelerated nods: Pazdur
Nov 17, 2022 3:36pm
Califf backs cancer czar's proposal to limit single-arm trials
Jul 29, 2022 11:33am
BIO chair mounts defense against accelerated approval reforms
Jun 28, 2022 10:40am
UPDATE: TG disbands cancer program after pulling U2 request
Apr 18, 2022 11:11am
